Pulse Biosciences (PLSE) Current Assets (2015 - 2025)

Pulse Biosciences' Current Assets history runs 11 years deep, the most recent figure standing at $83.4 million for Q4 2025.

• On a quarterly basis, Current Assets fell 30.16% year-over-year to $83.4 million in Q4 2025; TTM through Dec 2025 was $83.4 million, a 30.16% decrease from a year earlier, with the FY2025 full-year figure at $83.4 million, down 30.16% from the prior year.
• Current Assets slipped to $83.4 million in Q4 2025 per PLSE's latest filing, from $97.2 million in the prior quarter.
• Across five years, Current Assets topped out at $120.9 million in Q1 2025 and bottomed at $22.2 million in Q1 2022.
• The 5-year median for Current Assets is $60.9 million (2021), against an average of $64.1 million.
• Across the five-year window, Current Assets sank 64.24% in 2022 and jumped 297.08% in 2025, its largest moves.
• Year by year, Current Assets stood at $45.3 million in 2021, then jumped by 37.11% to $62.1 million in 2022, then retreated by 27.06% to $45.3 million in 2023, then soared by 163.52% to $119.4 million in 2024, then slumped by 30.16% to $83.4 million in 2025.
• Per Business Quant, the three latest PLSE Current Assets figures stand at $83.4 million (Q4 2025), $97.2 million (Q3 2025), and $108.2 million (Q2 2025).